Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
This distinction matters because tissue organization directly determines mechanical function and long-term durability
A place on the 503A list would give licensed compounding pharmacies a clear legal basis to prepare BPC-157 for individual patients with valid prescriptions
However, it is not approved for use in patients that are not HIV-positive
BPC-157 Read the full profile Site of action (Localized) Origin (Gastric juice fragment) Supports angiogenesis Typical research dose (200500 mcg/day) Typical frequency (12x daily) Typical cycle length (46 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) TB-500 Read the full profile Site of action (Systemic) Origin (Thymosin Beta-4 fragment) Supports angiogenesis Regulates actin / cell migration Typical research dose (25 mg/week) Typical frequency (23x weekly) Typical cycle length (48 weeks) Subcutaneous injection WADA-banned since 2022 Studied alone (no pairing required) Our top-rated vendor Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing no paid placements, no affiliate influence
The issue is cumulative exposure over time
US$ 22.22
US$ 28.48
US$ 22.76
US$ 29.65
